Authors
Latest:
Addressing resident burnout starts with program’s culture"I was overcome by the sinking notion that my career ambitions were regressing from thriving to surviving-a sentiment I know isn’t unique to my training. What may be unique, however, is how my program responded to increasingly evident signs of resident burnout," says James Anaissie, MD.
Latest:
How to bill for performing complex urodynamics"To answer this question, one must know what is and is not included in the global payment for the UDS, and the definition and instructions for appropriate use of modifier 25," write Jonathan Rubenstein, MD, and Mark Painter.
Latest:
Robotic ureteroscopy: The future of stone management?Advances in robotic URS will help target stones and reduce ionizing radiation.
Latest:
Robotic ureteroscopy: The future of stone management?Advances in robotic URS will help target stones and reduce ionizing radiation.
Latest:
Upper tract transitional cell carcinoma: Diagnostic and therapeutic considerationsDetermining grade of disease is important, as nephron-sparing approaches may be feasible.
Latest:
The case for transperineal prostate biopsy vs. the transrectal approachReduced infection rate may drive increased use of the transperineal approach.
Latest:
The case for transperineal prostate biopsy vs. the transrectal approachReduced infection rate may drive increased use of the transperineal approach.
Latest:
An end to the decline in prostate cancer mortality"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.
Latest:
An end to the decline in prostate cancer mortality"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.
Latest:
Bicycle riding: Good or bad for men’s health?Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.
Latest:
Bicycle riding: Good or bad for men’s health?Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.
Latest:
Updated AUA guidelines on BPH: What urologists need to knowThe updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.
Latest:
Updated AUA guidelines on BPH: What urologists need to knowThe updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Expert Perspectives on the VIOLETTE Study and Future Directions in Prostate Cancer ResearchAmir H. Lebastchi, MD, provides perspectives on the VIOLETTE study and underscores the importance of future head-to-head trials to gain a deeper understanding of various treatment approaches.
Latest:
MRI/TRUS fusion-guided biopsy using UroNavPinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
Latest:
MRI/TRUS fusion-guided biopsy using UroNavPinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
Latest:
Freehand biopsy with PrecisionPoint systemGeorge and colleagues demonstrate the use of the Michigan Urological Surgery Improvement Collaborative (MUSIC) template to perform a freehand transperineal prostate biopsy using the PrecisionPoint Transperineal Access System.
Latest:
UroView: Gallium 68 PSMA–Targeted PET Imaging in Prostate Cancer: Staging and OutcomesThis article features insights from Phillip Kuo, MD, PhD, and Andre Abreu, MD, on gallium 68 PSMA-targeted PET imaging in prostate cancer.
Latest:
New developments may change treatment of OAB"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.
Latest:
New developments may change treatment of OAB"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.
Latest:
Artificial intelligence is the new ghost author in urological research“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.
Latest:
Acute-care urology during the pandemic: Lessons learned"The goal of this narrative is to share details and lessons learned during our on-call urology coverage in the midst of the current pandemic so we can help others by informing planning," write Alexander Small, MD, and Rich Matulewicz, MD.
Latest:
Active Surveillance in Muscle Invasive Bladder CancerTypes of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.
Latest:
Addition to avelumab to best supportive care after firstline chemo improves OS in advanced urothelial CaAvelumab (Bavencio) as a maintenance treatment after chemotherapy significantly extended overall survival in patients with advanced urothelial cancer, according to findings from thephase III JAVELIN Bladder 100 trial.
Latest:
Management of UTUC using a kidney-sparing approachAdvances in endourology have made kidney-sparing treatments a viable treatment option.
